Gaurav Shah
CEO at Rocket Pharmaceuticals Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Rocket Pharmaceuticals Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Rocket Pharmaceuticals Inc. May 20, 202699.3%
-
Rocket Pharmaceuticals Inc. June 18, 202599.1%
-
Rocket Pharmaceuticals Inc. June 13, 202499.5%
-
Rocket Pharmaceuticals Inc. June 22, 202398.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 18, 2026 | Rocket Pharmaceuticals Inc. | Open-market sale | −2,293 | $3.38 | $7,750 |
| Aug 13, 2026 | Rocket Pharmaceuticals Inc. | Open-market sale | −2,837 | $3.38 | $9,589 |
| May 21, 2026 | Rocket Pharmaceuticals Inc. | Option exercise | +76,490 | $1.69 | $129,268 |
| May 21, 2026 | Rocket Pharmaceuticals Inc. | Open-market sale | −55,684 | $3.09 | $172,064 |
| May 19, 2026 | Rocket Pharmaceuticals Inc. | Open-market sale | −2,409 | $3.01 | $7,251 |
| May 13, 2026 | Rocket Pharmaceuticals Inc. | Open-market sale | −2,728 | $3.61 | $9,848 |
| Feb 18, 2026 | Rocket Pharmaceuticals Inc. | Open-market sale | −5,990 | $3.34 | $20,007 |
| Feb 13, 2026 | Rocket Pharmaceuticals Inc. | Open-market sale | −12,279 | $3.31 | $40,643 |
| Feb 11, 2026 | Rocket Pharmaceuticals Inc. | Grant or award | +286,028 | — | — |
| Nov 18, 2025 | Rocket Pharmaceuticals Inc. | Open-market sale | −6,276 | $2.98 | $18,702 |
| Aug 18, 2025 | Rocket Pharmaceuticals Inc. | Shares withheld for tax | −2,234 | $3.05 | $6,814 |
| May 20, 2025 | Rocket Pharmaceuticals Inc. | Open-market sale | −2,253 | $6.45 | $14,532 |
| May 16, 2025 | Rocket Pharmaceuticals Inc. | Open-market sale | −3,621 | $6.53 | $23,645 |
| Apr 10, 2025 | Rocket Pharmaceuticals Inc. | Open-market purchase | +20,000 | $5.08 | $101,600 |
| Feb 21, 2025 | Rocket Pharmaceuticals Inc. | Open-market sale | −16,303 | $10.58 | $172,486 |
Questions about Gaurav Shah
What boards is Gaurav Shah on?
Gaurav Shah sits on the board of Rocket Pharmaceuticals Inc.
What company is Gaurav Shah the CEO of?
Gaurav Shah is CEO of Rocket Pharmaceuticals Inc.
How long has Gaurav Shah served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.